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Abstract
Background: All diabetic neuroosteoarthropathy (Charcot arthropathy) treatment concepts are focused on a long-term
infection-free, ulcer-free, and plantigrade sufficiently stable foot in order to avoid amputation. Reconstructive
arthrodesis techniques for severe deformities are associated with high postoperative complication rates. This
study reports a detailed complication analysis and provides a strategy that may help detect patients at risk for a
complicated postoperative course.
Methods: The study comprised 43 feet in 37 patients with severe non-plantigrade or unstable Charcot deformity,
Eichenholtz stages II/III (Sanders and Frykberg types II-V), who underwent reconstructive arthrodesis of the
mid- and/or hindfoot. Patients were retrospectively enrolled 4.5 years postoperatively (range 1.8–11.2 years).
All patients showed at least two out of five positive Pinzur high-risk criteria (immuno-compromising illnesses,
large bone deformity, longstanding ulcer overlying infected bone, regional osteopenia, obesity). Follow-up
included a detailed clinical analysis and radiologic assessment with emphasis on complication analysis and
evaluation in accordance to the PEDIS classification system.
Results: Significantly lower overall complication rates, as well as re-operation, reulceration and amputation
counts were found for patients with a cumulative PEDIS count below 7. For PEDIS single criteria, significantly
lower overall complication rates were found for patients without signs of occlusive peripheral artery disease, an
ulcer extent <0.9 cm2, ulcer depth including erosion and inflammation of the skin and subcutaneous tissues
only. Soft-tissue complications affected 49 % of patients, hardware breakage 33 %, hardware loosening 19 %,
non-union 18 % and amputation 21 %. Radiographs revealed a correct reconstruction and restoration of all foot
axes postoperatively with partial recollapse at the lateral foot column; however, fixation strength for the medial
column was maintained.
Conclusions: Internal corrective arthrodesis for patients within the deformed stages of Charcot deformity can
provide adequate reconstruction, as assessed by intraoperative radiographic measures, that exhibit superior
long-term stability for the medial column. Despite a high risk patient population, a favourable outcome in
terms of overall complication, re-ulceration, and amputation rates for patients/feet with a cumulative PEDIS
count below 7 was found. The cut-off value of 7 may aid clinical decision-making during preoperative planning
for Charcot deformity.
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Background
The aim of any treatment concept involving neuroos-
teoarthropathy (Charcot arthropathy) for diabetic or
other neuropathic diseases is a long-term infection-free,
ulcer-free, and sufficiently plantigrade stable foot in
order to maintain the ability to walk independently and
avoid amputation [1, 2]. The search for the ideal treat-
ment strategy is a challenge for foot and ankle special-
ists; furthermore, general evidence-based treatment
algorithms are lacking and the literature is inconsistent
regard to both the ideal treatment option and treatment
timing because of the disease’s unrelenting progression.
The disease progression may lead to a loss of osteo-
ligamentous architecture and consequently loss of the
plantigrade foot alignment; thus, inducing subsequent
soft tissue complications such as skin breakdown, re-
current ulcerations, and infections [1, 3]. Neuroosteoar-
thropathic patients with chronic ulceration have a 12
times higher risk of amputation, compared to those
with ulcer-free feet [4]. Ulceration characteristics are
described by the widely-used PEDIS classification sys-
tem developed by the International Working Group on
Diabetic Foot (IWGDF) [5, 6]. It describes five specific
ulcer criteria; perfusion, extent, depth/tissue loss, infec-
tion, and sensation; each criterion is graded by severity
(Fig. 1).
With non-operative treatment with total contact casts
or walkers, a long-term ulcer-free foot can be achieved
Grade Symptoms
Perfusion P1 No symptoms/signs of PAD
P2 Symptoms/signs of PAD, but not of CLI
P3 CLI
Extend/size E Wound size (measured in square centimetres)
Depth/tissue lost D1 Superficial full thickness ulcer, not penetrating any 
structure deeper than the dermis
D2 Deep ulcer, penetrating below the dermis to 
subcutaneous structures, involving fascia, muscle, or 
tendon
D3 All subsequent layers of the foot involved, including 
bone and/or joint (exposed bone, probing to bone)
Infection I1 No symptoms or signs of infection
I2 Infection involving the skin and the subcutaneous tissue 
only (without involvement of deeper tissues and without 
systemic signs); at least 2 of the following items are 
present:
- local swelling or induration,
- erythema > 0.5 to 2 cm surrounding the ulcer
- local tenderness or pain
- local warmth
- purulent discharge 
I3 Erythema > 2 cm plus one of the items described above 
or infection involving structures deeper than skin and 
subcutaneous tissues (abscess, osteomyelitis, septic 
arthritis, fasciitis) without systemic inflammatory 
response signs
I4 Any foot infection with the following signs of a SIRS 
manifested by two or more of the following conditions:
- Temperature >38 or <36 Celsius
- Heart rate > 90 beats/min
- Respiratory rate > 20 breaths/min
- PaCO2 <32 mm Hg
- White blood cell count >12,000 or <4,000/cu mm
- 10% immature (band) forms
Sensation S1 No loss of protective sensation
S2 Loss of protective sensation with absent pressure 
sensation on 2 of 3 sites on the plantar side of the foot or 
absent vibration sensation or vibration threshold >25 V 
on the hallux
Fig. 1 PEDIS classification system according to IWGDF Guidelines (International Working Group on the Diabetic Foot [5, 6]). Legend: PAD:
peripheral arterial disease; CLI: critical limb ischemia; SIRS: systemic inflammatory response syndrome
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in approximately 60 % of patients if plantigrade foot
alignment can be established (early stage I/II applying
the Eichenholtz classification system) [1]. Patients with
an advanced degree of deformity and mid- and/or hind-
foot instability experience less favourable results after
non-operative treatment. Multiple recastings and pro-
longed disability are the consequences, and 40–51 % of
Charcot patients may need surgical treatment at some
point in the disease’s progression [1, 7, 8]. At this time
point, when signs of instability and progressive ma-
lalignment are present, reconstruction arthrodesis
techniques are indicated [1, 9, 10]. Reconstruction
arthrodesis techniques vary from external fixation tech-
niques such as ring fixators to internal fixation tech-
niques such as plates, screws, or bolts (or combinations
of these techniques) [1, 2, 9, 11, 12]. Due to the absence
of general algorithms, the treatment option is usually
determined by individual patient factors and the sur-
geon’s expertise [1].
For surgery in Charcot disease patients, prolonged
healing periods, high rates of infectious complications,
non-union and malunion, stress fractures, fixation fail-
ure, metal-induced soft-tissue irritation, implant break-
age or loosening, and concomitant high re-operation
rates are frequently described [1, 7, 11–18]. Due to these
multiple disadvantages, in 2007 Pinzur et al. [1, 15] pro-
posed that patients with high risk criteria such as a large
bone deformity, an longstanding ulcer overlying infected
bone, regional osteopenia, obesity, or immunocompro-
mising illnesses do not qualify for open reduction and
internal fixation. Instead, in these cases, percutaneous
correction and fixation with an external ring fixator is
recommended. Only in cases of available low-risk cri-
teria (no open wounds, no history of deep infection,
good bone quality, minimal diabetes-associated comor-
bidity, no morbid obesity), internal corrective arthrodesis
is recommended [1, 15]. However this recommendation
was based on the experience of one single surgeon and
no detailed algorithm was provided [1]. Thus, it remains
unclear how many high- or low-risk criteria are applic-
able to achieve the desired outcome.
In view of the foregoing, we retrospectively evaluated
a consecutive series of neuroosteoarthropathic patients
who underwent corrective arthrodesis of late stage Char-
cot mid- and hind-foot neuroosteoarthropathy with at
least two out of the five positive Pinzur high-risk criteria.
A 4.5 years follow-up was conducted to determine
whether internal corrective arthrodesis could provide
the desired outcome of a foot that was infection-free
and ulcer-free for a long period, despite the presence of
positive high risk criteria. The results were then quanti-
fied based on the PEDIS criteria in order to evaluate
those patients that may qualify for internal corrective
arthrodesis despite Pinzur high-risk criteria.
Methods
The study comprised 43 feet in 37 patients with severe
Charcot neuroosteoarthropathy who underwent internal
corrective arthrodesis from November 2005 to March
2012 and were retrospectively reviewed. The indication
criteria for corrective arthrodesis were: (1) a clinically
and radiographic non-plantigrade foot alignment; (2) a
high degree of instability of the medial or/and lateral
midfoot and/or hindfoot region proven by clinical exam-
ination and visualized by the changes of radiologic axes
as described by Sammarco et al. [19]: positive talar-first
metatarsal angle in anterior-posterior (AP) views, nega-
tive talar-first metatarsal angle in lateral views, negative
calcaneal-fifth metatarsal angle in lateral views, and devi-
ations from the neutral axis in Saltzman views; (3) the
foregoing, plus clinically manifest or impending ulcer-
ation of soft tissues overlying bony deformity; and (4)
failed primary conservative treatment.
The mean patient age (24 males; 13 females) was 56.7 ±
8.5 years (range 29–76). All but two patients suffered from
type 2 diabetes (n = 31) or type 1 diabetes (n = 4) with in-
sulin dependency in 94 % of the cases (n = 33). Twenty-
eight patients (76 %) suffered from three or more than
three secondary diagnoses. Thirty-three feet (77 %) were
operated during the consolidation phase (Eichenholtz
stage III). Ten feet (23 %) presented with stage II arthropa-
thy (coalescence). Applying the topographic classification,
according to Sanders and Frykberg, a mid-foot affection
type II and/or III, corresponding to the Lisfranc and Cho-
part joint region, was visible in all feet; however, 15
radiographs showed an additional involvement of the sub-
talar and talocalcaneal joints, according to Sanders and
Frykberg type IV.
The preoperative assessment included anterior-posterior
and lateral weight-bearing radiographs of the foot and
ankle joint, including Saltzman views based on the follow-
ing described angles. In case of doubt regarding the
peripheral vascular status, color-coded duplex sono-
gram was performed before surgery to reveal patients
with relevant macroangiopathy. Subsequently, angio-
graphic dilatation and stenting was performed in two
patients preoperatively.
The location of the corrective osteotomy and arthrod-
esis was determined according to radiologic and clinical
assessment, and stabilization was performed using spe-
cific implants in order to achieve maximum stability.
The procedure was as follows. A medial utility incision
exposed the medial column as well as the talonavicular,
naviculocuneiform, and tarsometatarsal joints for either
osteotomy, excision of the bony deformity, or denuding
the joint surfaces from cartilage was performed as well
as resection of necrotic bone; this was done in pre-
paration for fusion and reconstruction of a plantigrade
foot position. Stabilization of the medial column was
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performed in 21 feet (49 %) using extramedullary de-
vices, of which 9 feet (21 %) received angular stable
plates and 9 feet (21 %) received intramedullary implants
only. Seven feet (16 %) were stabilized using a combin-
ation of intra- and extra-medullary implants (Table 1).
With isolated collapse of the medial column, the hind-
foot and lateral foot region remained untouched. Add-
itional stabilization of the lateral column was performed
in 22 feet (51 %); 6 of these feet (14 %) were stabilized
with angular stable plates. Hindfoot arthrodesis was
performed in 16 cases (37 %) using compression screws
(n = 9; 21 %), angular stable plates (n = 6; 14 %) or lock-
ing nails (n = 1; 2 %). In order to reconstruct the osseous
foot geometry, resection of the necrotic midfoot/hind-
foot bones was necessary in 7 feet (16 %). In 30 cases
(70 %), osseous defects were filled with autologous iliac
crest grafts. One case (2 %) required lengthening of the
gastrocnemius-soleus complex. In 3 cases (7 %), Achilles
tendon lengthening via the Dockery technique was per-
formed as indicated by intraoperative evaluation of tight-
ness of the Achilles and gastrocnemius tendon complex.
Postoperatively, a lower leg splint was applied and
replaced by a total contact cast with soft tissue consoli-
dation. Mobilization was performed with partial weight-
bearing of 20 kg if possible. Routine follow-up e.g., for
cast replacement and radiographs, was conducted two
weeks after hospital discharge and then at monthly
intervals until radiographic bony consolidation was
proven. Subsequently annual follow-up visits were estab-
lished. Follow-up ended if amputation occurred. Mean
follow-up averaged 4.5 ± 6.6 years (range 1.8–11.2).
The 4.5 years follow-up included a detailed failure ana-
lysis for the peri- and post-operative time period, focus-
ing on complication and re-operation rates. Therefore,
early (30 days postoperatively), intermediate (30 days to
5 months postoperatively) and late complications (from
postoperative month 6 onward) were recorded and
assessed according to their degree of severity and the
need for either further surgery or conservative regime.
All patients were then graded according to the PEDIS
classification system [5, 6, 20] and Pinzur criteria [1, 15].
The former, developed by the International Working
Group on the Diabetic Foot (IWGDF), describes the dia-
betic foot depending on severity of the following charac-
teristics: lower leg/foot perfusion, ulcer extent, ulcer
depth/tissue loss, infection, and sensation [5, 6, 20]. The
latter, published by Pinzur in 2007 [1, 15], distinguishes
high-risk criteria as a large bone deformity, a longstand-
ing ulcer overlying infected bone, regional osteopenia,
obesity, or immuno-compromising side illnesses, as well
as low-risk criteria such as absence of open wounds, no
history of deep infection, good bone quality, minimal
diabetes-associated comorbidity, and absence of morbid
obesity. On the basis of this Pinzur grouping [1, 15] and
PEDIS criteria [5, 6, 20] a complication analysis was per-
formed with the goal of evaluating those patients at risk
who do not qualify for internal corrective arthrodesis.
Furthermore, patient mobilization and casting length
were registered.
A detailed radiologic follow-up included measurement
of the AP talar-first metatarsal angle, lateral talar-first
metatarsal angle, calcaneal-fifth metatarsal angle, dorsal
midfoot displacement in pre-, post- and follow-up radio-
graphs. The mean values are given in absolute numbers
representing the change of angulation for the AP talar-
first metatarsal angle; however, the range is given with
algebraic signs; thus, negative values correspond to ab-
duction deformity and positive values correspond to ad-
duction deformity of the forefoot. Twenty-nine feet were
available with complete radiologic follow-up.
Ethics, consent and permissions
The study was approved by the local ethical committee
under the document no. A 2014–0174 (2014/11/27) and
is in accordance with the declaration of Helsinki. All pa-
tient’s gave consent to participate.
Statistical analysis
Results are given as mean ± SEM (range). After satisfy-
ing the assumption of normality (Kolmogorov), the
paired t-test analysis or the Mann–Whitney U Test
(non-normal distribution) were performed to analyse the
differences in radiographic parameters. For differences
in complication rates, according to preoperative PEDIS
single criteria (“P” perfusion, “E” extent, “D” depth, “I”
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infection, “S” sensation); cumulative PEDIS count groups
were developed and a paired t-test analysis was
performed. Complication counts, re-operation and re-
ulceration rates, amputation counts, and length of
immobilization were analysed in relation to the cumula-
tive PEDIS count by comparing the group below the
boundary value as defined above and hereafter. The
boundary value was initially set as the cumulative PEDIS
mean value (6.5 ± 2.3), then, one SEM value (8.8) was
added to the mean value, and then two SEM values
(11.1) were added to the mean value. Significance was
defined at p < 0.05. For assessment of complications, re-
operation, re-ulceration, number of amputations, and
length of immobilization dependent upon lower leg/foot
perfusion, P1 was compared to P2 and P3. Dependent
upon the depth of ulceration, D1 was compared to D2
and D3 (and D1 and D2 were compared to D3).
Dependent upon the presence of local infection, I1 was
compared to I2, I3, and I4 (and I1 and I2 were compared
to I3 and I4). Sensation was not further considered since
all patients showed a loss of protective sensation (S2).
For the ulcer extent, results were compared based on
the cumulative PEDIS value (ulcer extent as mean 0.9 ±
0.2 cm2). Statistical analysis was performed using IBM




All patients/feet showed a minimum of 2 out of 5 posi-
tive Pinzur high-risk criteria (mean 3.1 ± 0.1; range 2–5,
Fig. 2). According to Pinzur [15], all feet were at high
risk for postoperative complications. The following com-
plication analyses focused on soft tissue complications,
implant associated complications, non-union (stable/
non-stable) and amputation; these complications were
determined during the first run of the analyses. Almost
half (20 of 43 feet; 46.5 %) developed a mean 0.51 ± 0.1
early complications, 26 feet (61.0 %) developed inter-
mediate complications (mean 0.81 ± 0.1), and 31 feet
(72.1 %) developed late complications (mean 1.79 ± 0.2).
Soft tissue complications occurred in 34 feet (79 %) of
29 patients (67 %) during the follow-up period. Specific-
ally, 21 feet (49 %) developed superficial wound infec-
tions, 16 feet (37 %) developed (re)ulceration, and 15
feet (35 %) had impaired wound healing. Osteomyelitis
affected 4 feet (9 %). About half (52 %; n = 40) of the
soft tissue complications occurred during the late
follow-up phase, 27 % (n = 21) developed within the
early phase, and 21 % (n = 16) occurred within the inter-
mediate phase.
Hardware-associated complications affected 22 feet
(51 %) of 21 patients (49 %); hardware breakage, which
might affect single screws, occurred in 14 feet (33 %)
and hardware loosening occurred in 8 feet (19 %). In 8
feet (18 %), non-union of the arthrodesis region was ob-
served. Both hardware-associated complications and
non-union occurred most frequently in the late phase
(54 %); however, 42 % were observed within the inter-
mediate phase.
Amputation had to be performed on 9 patients (21 %),
with a need for lower leg amputation in 6 cases (14 %),
forefoot Chopart amputation in one case (2 %), and toe
amputation in 2 cases (5 %). Amputation was performed
at a mean 1.1 ± 0.8 years (range 0–3) after initial surgery.
For complication management, 1.9 ± 4.0 (range 0–5;
64 %) complications of a mean 2.9 ± 3.5 complications
(range 0–7, n = 131) had to be resolved surgically. In 14
cases (33 %), only minor revision surgery such as soft-
tissue debridement or jet lavage were necessary. In 20
Fig. 2 Classification according to Pinzur’s criteria [1, 15]
Eschler et al. BMC Musculoskeletal Disorders  (2015) 16:349 Page 5 of 11
cases (47 %), major surgery as rearthrodesis or amputation
was performed, among which 16 cases (37 %) underwent
minor revision surgery during follow-up as well (Table 2).
This resulted in a mean of 3.1 ± 5.0 (range 0–10) revision
surgeries. Regarding the time point of complication reso-
lution, 18 % of early complications, 25 % of intermediate
complications, and 57 % of late complications required
surgical complication management.
Complication analyses considering PEDIS criteria
Taking into consideration the preoperative cumulative
PEDIS count and the single PEDIS criteria (Fig. 1), a dif-
ferentiated analysis was performed to ascertain those
high-risk patients who qualify for internal corrective fix-
ation techniques, despite a Pinzur high risk rating.
The mean cumulative PEDIS count accounted for
6.5 ± 2.3 (range 0–14). When comparing the groups
with ≥7 and <7 cumulative PEDIS counts, a signifi-
cantly lower overall complication rate for the <7 group
(p < 0.01), as well as a significant lower re-operation
(p < 0.05), re-ulceration (p < 0.03) and amputation
counts (p < 0.01) were revealed (Fig. 3a). By differenti-
ating early, intermediate, and late complications only the
latter (late) were significantly reduced (p < 0.01). When
adding one SEM to the mean value (6.5 + 2.2 = 8.8); thus,
comparing the groups ≥9 and <9, cumulative PEDIS value
analogue results were achieved as shown in Fig. 3b.
Only the criterion of re-ulceration showed non-significant
results. When adding two SEM to the mean value (8.8 +
2.2 = 11.0); thus, comparing the groups ≥11 and <11 cu-
mulative PEDIS values, no significant differences were
found. This reveals a higher risk for complications among
patients with a cumulative PEDIS count ≥7.
The analyses of PEDIS under the single criterion of
perfusion (“P”) showed a significantly lower overall com-
plication rate when no symptoms or signs of peripheral
artery occlusive disease (PAD) were apparent when
compared to feet with symptoms or signs of PAD or
manifest critical limb ischemia (CLI) (P1 vs. P2 and P3;
p < 0.05; Fig. 4). In addition, apparent complications
were significantly more amenable to successful conserva-
tive treatment (p < 0.05).
For the ulcer extent (“E”; 8.8 ± 0.2 cm2; range 0–6), sig-
nificantly lower overall complication rates (p < 0.01) and
amputation rates (p < 0.05) were found for a preoperative
ulcer extent of <0.9 cm2. Again, apparent complications
were significantly more amenable to successful conserva-
tive treatment (p < 0.05).
Applying the criterion of ulcer depth/tissue loss (“D”)
significantly lower overall complication rates (p < 0.01), re-
operation rates (p < 0.03) and amputation rate (p < 0.01)
were found with the comparison of superficial full-
thickness ulcers/erosions (grade 1) to ulcers penetrating
below the dermis (grade 2) or ulcers penetrating all deeper
layers of the foot, including bone/joints (grade 3) (D1 was
compared to D2 and D3). Again, apparent complications
were significantly more amenable to successful conserva-
tive treatment (p < 0.01).
The criterion of infection (“I”) revealed significant re-
sults in all parameters when comparing feet with no
signs of infection (I1) to any signs of infection (I2, I3
and I4), complication rate (p < 0.01), re-operation rate
(p < 0.01), re-ulceration rate (p < 0.01), and amputation
rate (P < 0.05). Comparing those with inflammation of
the skin and subcutaneous tissue (I1 and I2) to those
with extensive erythema deeper than the skin and sub-
cutaneous tissue (I3), only the overall complication rate
reached persistent significant differences (p < 0.01).
Radiological results
The mean talar-first metatarsal angle in an AP view of the
foot, as an indicator for abduction/adduction midfoot de-
formity, improved from 8.4 ± 4.2° (range –17 to +31) pre-
operatively to 4.6 ± 3.3° (range –8 to +23) postoperatively,
but slightly decreased to 5.6 ± 3.9° (range 24 to +17) at
final follow-up. An effective 3.8 ± 5.5° (range –11 to +22)
correction to the neutral (0°) axis was achieved postopera-
tively; it decreased slightly to 2.8 ± 6.5° (range –18 to +41)
at final follow-up. Full correction to the anatomic neutral
position (0°) axis was observed in 83 % (n = 24) of the feet.
In 38 % of patients (n = 11) an overcorrection with change
of algebraic sign was observed. Due to the observed recol-
lapse, 66 % (n = 19) of patients showed correct AP talar-
first metatarsal angle at final follow-up (Table 3).
The mean lateral talar-first metatarsal angle showed
significant improvements of +15.0 ± 7.6° (range: –9 to
+34; p < 0.01) postoperatively, compared to preoperative
values. At final follow-up an improvement of +6.6 ± 7.7°
(range –33 to +18; p < 0.01) was found; this loss of re-
duction was significant. Ideally, the intraoperative
change of the lateral talar-first metatarsal angle exhibited
a high positive value, corresponding to a change from a
valgus deformity to a neutral axis, therefore, erection of
the foot arch. This was achieved in 96.6 % (n = 28) of
Table 2 Type of revision surgery performed on study patients
Revision surgery All Early Intermediate Late
n % n % n % n %
Corrective Arthrodesis 24 55.8 1 2.3 7 16.3 16 37.2
Local osseous resection 2 4.7 - - 1 2.3 1 2.3
Implant removal 18 41.9 - - 10 23.3 8 18.6
Amputation 9 20.9 1 2.3 2 4.7 6 13.9
Othersa 34 39.1 14 16.1 4 4.6 16 18.4
asoft tissue debridement, jet lavage, antibiotic chain placement/replacement,
haematoma evisceration, split-skin grafting, closed amputation, muscle or
musculocutaneous flaps, fracture osteosynthesis
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the patients postoperatively and was still observed in
62.1 % (n = 18) at final follow-up.
The calcaneal-fifth metatarsal angle in the lateral view
displaying the lateral foot arch is optimally erected to in-
traoperative positive values. The calcaneal-fifth metatarsal
angle improved significantly with +7.2 ± 7.1° (range –8
to +22; p < 0.01) when the pre- and post-operative
values in our study population were compared;
however, it decreased to –1.8 ± 8.9 (range –16 to +16;
p < 0.01) at final follow-up, thus, denoting a recollapse
of the lateral foot arch in mean. However, postoperatively,
93 % (n = 26) of patients showed correct reduction of the
lateral foot arch, and ultimately, 35 % (n = 10) showed
correct reduction at final follow-up.
Since standard angles on lateral radiographs tend to
underestimate the grade of deformity with midfoot joint
displacement [19], the dorsal midfoot displacement
(lateral view x-ray; the vertical distance at the level of
dislocation between the talar midline axis and the first
metatarsal axis) was measured. Dorsal midfoot dis-
placement showed significant postoperative improve-
ments of +9.5 ± 9.2 mm (range –9 to +32; p < 0.01)
and slight bone loss; however, a +5.9 ± 9.4 mm correc-
tion (range 22 to +26; p < 0.05) was observed at final
follow-up. This means that in 83 % (n = 24) of the pa-
tients postoperatively, and ultimately 59 % (n = 17) at
final follow-up achieved adequate correction.
Hospitalization and mobilization
Mean hospitalization duration following the initial sur-
gery was 28.3 ± 14.4 days; the minimum duration of
stay was 8 days, the maximum 87 days caused by a very
complicated course of one patient. The mean postoper-
ative casting period was 2.5 ± 3.7 months (range 0.3–7
months).
At final follow-up, 60 %, of the patients (n = 26) were
fully mobile without a need for walking aids; 7 patients
(16 %) used non-orthopaedic shoes and 19 patients (44 %)
used orthopaedic shoes. Therefore, the goal of long-term
walking independence was reached. Seven patients (16 %)
wore a prosthesis. Only 1 patient (2 %) used a wheelchair,
2 patients (5 %) used a walker, and 5 patients (12 %) used
a cane.
Discussion
For diabetic neuroosteoarthropathy treatment general
evidence-based treatment algorithms are lacking and the
literature is inconsistent regarding both the ideal treat-
ment type and timing of treatment due to its unrelenting
progression. With disease progression and unstable non-
plantigrade alignment of the mid- and hind-foot, a high
degree of skin breakdown and ulceration at the site of
bony deformities occurs [1, 3]. Pinzur [1, 8] and other
authors [21, 22] proposed the main goals: an infection-
free and ulcer-free foot for a long duration together with
the ability to use commercially-available depth-inlay
shoes and custom-accommodative foot orthoses for
maintaining long-term walking independence. Non-
surgical measures such as total contact casting represent
the treatment option of choice in cases of plantigrade
foot positioning [19, 23, 24]. However, the progressive
character of instability is associated with a serious im-
pairment of the quality of life and an estimated risk of
up to 49 % to develop recurrent ulceration together with
a high risk for further complications such as infections
or eventually amputation [23, 25]. Therefore, early re-
constructive surgery is suggested by several authors as a
valuable treatment option in the presence of severe de-
formity [25–28]. Evidence-based literature does not
exist, but clinical reports stress that stability can be re-
stored with precise surgical technique, appropriate
Fig. 3 Overall complication rates (a) and re-operation rates (b) according to the cumulative PEDIS count [5, 6; Fig. 1]
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perioperative education, and postoperative therapy (as-
suming adequate patient compliance) [2, 27]. Neverthe-
less, according to Pinzur [1], certain high-risk criteria such
as a large bone deformity, a longstanding ulcer overlying
infected bone, regional osteopenia, obesity, or immuno-
compromising illness showed increased complication rates
and therefore interfere with open reduction and internal
fixation. Instead, percutaneous correction and fixation
with an external ring fixator is recommended for high-risk
constellations
In patients with low-risk criteria, internal corrective
arthrodesis is recommended [1]. Low-risk criteria in-
clude absence of open wounds, no history of deep infec-
tion, good bone quality, minimal diabetes-associated
comorbidity, and absence of morbid obesity. Actually,
the diagnosis of Charcot deformity is frequently delayed
and only made in the deformed stages [29]. Conversely,
despite prompt immobilization and protected weight-
bearing, some patients develop severe deformities [29].
We retrospectively reviewed 43 feet with a deform-
ation stage consistent with Charcot disease and deter-
mined as a high-risk group, which had at least two
positive high-risk criteria according to Pinzur [1]. During
a 4.5 years follow-up, a detailed complication analysis
was performed which revealed high complication rates.
The early postoperative period was characterized by soft
tissue complications in which 75 % of patients were
affected by immediate postoperative wound infections
(47 %); this finding may be attributable to the endan-
gered diabetic patient population [3] and concurs with
Fig. 4 Complication evaluation applying the PEDIS classification system [5, 6]. Legend: *significant values (p < 0.05)
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rates of 7–26 % reported by other studies with an mean
of 2.5 years of follow-up [13, 23]. The osteomyelitis rate
was 9 % in our study population. It is reported to range
from 12 % to 16 % after reconstructive surgery in other
studies [13, 30]. However, our osteomyelitis rate is mark-
edly lower than the 33 % osteomyelitis rate after
conservatively-treated diabetic foot infections [31].
About one third (31 %) of the patients suffered from
hardware breakage and 18 % developed hardware loos-
ening with consecutive non-union. Sammarco et al. [19]
observed similar rates with 32 % implant breakage in
their 4.3 years of follow-up after midtarsal arthrodesis. A
recent review [2], including 95 Level IV and V studies,
revealed similar results and ulcer-free feet in most cases;
however, it described a 22.4 % non-union rate. Implant
or technique-associated problems, as well as the pro-
longed healing period in the altered diabetic metabolism,
are likely to be causal [32]. Nevertheless, currently there
is consensus that even with incomplete union, an ulcer-
free plantigrade foot may be achieved [2]. We also ob-
served 9 cases (20 %) with amputation, resulting in an
annual amputation rate of 4.4 %, which concurs with
Saltzman et al. [25] who reported on a cohort of 115 pa-
tients with a mean of 3.8 years of follow-up; they found
an annual amputation risk of 2.7 % of cases without ul-
ceration and an amputation risk of 28 % in cases with
ulceration. These cases incurred a 23 % risk of requiring
more than 18 months of casting and a high risk of about
49 % for recurrent ulceration. In our study population,
36 % of the patients suffered from recurrent ulcerations.
Illgner et al. [11] reported on 205 patients with an exter-
nal fixator and a follow-up period of 21 months; they
found a 25 % re-ulceration rate. A study of 115 conser-
vatively treated patients with 3.8 years of follow-up by
Saltzman et al. [25] showed 49% re-ulceration rates.
Altogether, we observed 2.9 complications/foot leading
to the question: “Can those patients at risk for a compli-
cated postoperative course be detected in preoperative
planning?”.
In view of the foregoing we developed a potential
predictor that would reveal those high-risk patients
qualifying for internal corrective arthrodesis despite
this risk. It was to take the PEDIS single group of cri-
teria into account: feet without signs of PAD, an ulcer
extent <0.9 cm2, an ulcer depth up to erosion, and in-
flammation including only skin and subcutaneous tissue.
This group of criteria alone showed significantly lower
overall complication rates (P1, E1, D1, I2, (S)). For this
Table 3 Radiographic evaluation
Radiographic angle mean min Max SEM p*
talar-first metatarsal angle (AP)a pre-surgery 8.4 −17.1 30.8 4.2
-
post-surgery 4.6 −7.9 23.0 3.3
final follow-up 5.6 −23.5 17.0 3.9
Correction post-surgery 3.8 −10.7 21.8 5.5
Correction final follow-up 2.8 −17.5 40.6 6.5
talar-first metatarsal angle (lat.)a pre-surgery −12.5 −28.5 14.9 8.8
*a <0.01, *b <0.01, *d <0.01
post-surgery 2.5 −11.8 28.1 7.3
final follow-up −5.9 −28.2 18.5 8.8
Correction post-surgery 15.0 −9.2 33.8 7.6
Correction final follow-up 6.6 −33.2 17.5 7.7
calcaneal-fifth metatarsal angle lat.)a pre-surgery 10.8 −8.1 29.0 7.5
*a <0.01, *b <0.01, *d <0.01
post-surgery 18.0 0.1 40.7 6.9
final follow-up 9.0 −11.8 33.0 5.2
Correction post-surgery 7.2 −7.9 21.5 7.1
Correction final follow-up −1.8 −15.5 15.6 8.9
dorsal midfoot displacementb pre-surgery 16.7 0.0 34.7 7.0
*a <0.01, *c <0.05
post-surgery 7.2 0.0 28.7 4.3
final follow-up 10.8 1.6 33.6 5.2
Correction post-surgery 9.5 −8.8 32.4 9.2
Correction final follow-up 5.9 −21.6 25.8 9.4
*significant values; *a pre-surgery vs. post-surgery’ *b post-surgery vs. follow-up; *c pre-surgery vs. follow-up; *d correction post-surgery vs. correction
final follow-up
a Values given in °
b Values given in mm
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degree of ulceration, the data also significantly predict
lower amputation rates and for this degree of ulceration
depth, they significantly predict lower amputation and re-
operation rates. Since all factors but sensation showed sig-
nificant influences on complication rates, we think that
the cumulative PEDIS count rather than the PEDIS single
criteria is practicable for clinical use because the former
takes the entire patient into consideration. This study sig-
nificantly revealed a favourable outcome in terms of over-
all complication, re-ulceration, and amputation rates for
patients/feet with a cumulative PEDIS count below 7. The
cutoff value of 7 may aid clinical decision-making in pre-
operative planning for a Charcot deformity and an in-
ternal corrective arthrodesis. By implication, these results
endorse the importance of early diagnosis for optimal
treatment planning.
In regard to radiologic evaluation, the goal of recon-
struction is to correct the non-plantigrade foot position
and to establish a neutral AP tarso-first metatarsal angle,
a positive lateral tarso-first metatarsal angle, a calcanear-
fifth-metatarsal angle, and a dorsal midfoot displacement
correction to normal values. Correction was completely
achieved in 83 % of the AP talar-first metatarsal angle,
in 97 % of patients for the lateral talar-first metatarsal
angle, 90 % of patients for the calcaneal-fifth metatarsal
angle and 83 % of patients with dorsal midfoot displace-
ment; these findings concur with those of other studies
[19, 30]. In addition, at final follow-up a significant
recollapse of the longitudinal foot arch for both the
medial column and, to a greater extent, the lateral col-
umn had to be observed in order to minimize the num-
ber of patients with persistent correction to 62 %
medially and 35 % laterally. Correction of AP talar-first
metatarsal angle recollapsed in 17 % of feet. Recollapse
of the midfoot, measured by the dorsal midfoot dis-
placement, lowered radiographic success rates to 59 %
of the patients. Wiewiorski et al. [30] similarly ex-
perienced the worst recollapse rate for the lateral
tarso-first metatarsal and calcanear-fifth-metatarsal an-
gles. Those radiographic measurements reveal a good
overall reliability for reconstructive techniques in our
patient population. The significance of those radio-
graphic measurements in regard to patient satisfaction
is unknown [30]; this adds to the difficulty of radio-
graphic evaluation, due to its putative measurement
error, to determine weaknesses of this study. In
addition, we noted another limitation: patient satisfac-
tion was not evaluated in this study. This limitation is
of significant importance. By forming groups based on
clinically defined boundaries, heterogeneous cohorts
may result, thus, leading to a statistical error. The
study design was retrospective with specific inclusion
criteria. Therefore, the limited patient sample nega-
tively impacted generalizations.
Conclusions
Internal corrective arthrodesis in the more advanced
stages of Charcot deformity can provide adequate recon-
struction with intraoperative radiographic measure-
ments. Superior stability was achieved for the medial
column in this 4.5 years follow-up period with the lateral
column showing less stability and a tendency to recol-
lapse. Despite the favourable radiologic results, overall
complication rates were high. A good predictor imple-
menting Pinzur and PEDIS criteria was developed to
identify those high-risk patients qualifying for uncompli-
cated internal corrective arthrodesis. Despite two-to-five
positive Pinzur high-risk criteria, a favourable outcome
in terms of overall complication, re-ulceration, and ampu-
tation rates for patients/feet with a cumulative PEDIS
count below 7 was found. The cutoff value of 7 may aid
clinical decision-making during preoperative planning for
Charcot deformity and internal corrective arthrodesis.
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